You are here: Home » Companies » Results
Cipla Q3 net up 10% to Rs 801 cr, posts highest ever quarterly sales in US
icon-arrow-left
Business Standard

Dr Reddy's Lab Q3 net up 77% at Rs 1,247 cr, revenue from operations jump

Dr Reddy's Laboratories on Wednesday reported a 77 per cent increase in its consolidated net profit at Rs 1,247 crore in the third quarter ended December 31, 2022

Topics
Dr Reddy's Laboratories Limited | Q3 results | Healthcare sector

Press Trust of India  |  Hyderabad 



Dr Reddy’s Laboratories chairman Satish Reddy
Dr Reddy’s Laboratories chairman Satish Reddy

Dr Reddy's Laboratories on Wednesday reported a 77 per cent increase in its consolidated net profit at Rs 1,247 crore in the third quarter ended December 31, 2022.

The drug firm had reported a net profit of Rs 706 crore in the October-December period of the previous fiscal.

Revenue from operations rose to Rs 6,770 crore during the period under review as against Rs 5,320 crore in the year-ago period, Dr Reddy's Laboratories said in a regulatory filing.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Wed, January 25 2023. 17:37 IST

RECOMMENDED FOR YOU

.